{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:03:22Z","timestamp":1792717402806,"version":"4.5.0"},"reference-count":17,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T00:00:00Z","timestamp":1500854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Endovasc Ther"],"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:p>Purpose: To evaluate the risk of postimplantation syndrome associated with endovascular aneurysm sealing (EVAS) and endovascular aneurysm repair (EVAR) in patients treated for abdominal aortic aneurysm (AAA). Methods: From December 2013 to May 2015, 41 AAA patients treated with EVAS (mean age 72\u00b19 years; 38 men) and 63 with EVAR (mean age 74\u00b110 years; 55 men) at a single center were retrospectively reviewed. To control for treatment selection bias, propensity score matching was used to compare outcomes by treatment mode. Main outcomes were postimplantation syndrome (defined as temperature &gt;38\u00b0C and leukocyte count &gt;12,000\/\u00b5L), inflammatory response markers [platelets and high-sensitivity C-reactive protein (hs-CRP)], and clinical complications through 30 days. Results: In 39 matched patients per group, the incidences of postimplantation syndrome (p=0.07), mean body temperature (p=0.05), mean leukocyte count (p=0.003), and mean hs-CRP (p&lt;0.001) were proportionally lower with EVAS vs EVAR. Serious adverse events (0% vs 12.8%, p=0.05) and endoleaks (0% vs 10.3%, p=0.13) through 30 days were less frequent with EVAS, but the group differences were not significantly different. The choice of endovascular graft material influenced postoperative and 30-day clinical outcomes, with greater overall risk observed with polyester stent-grafts. Conclusion: Endovascular aneurysm sealing is associated with a blunted systematic inflammatory response compared with EVAR. Polyester stent-grafts induce the greatest periprocedural inflammatory response.<\/jats:p>","DOI":"10.1177\/1526602817722019","type":"journal-article","created":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T05:21:30Z","timestamp":1500873690000},"page":"670-674","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":27,"title":["A Propensity Score\u2013Matched Analysis of Inflammatory Response With Endovascular Aneurysm Sealing vs Endovascular Aneurysm Repair"],"prefix":"10.1177","volume":"24","author":[{"given":"Patrick","family":"Berg","sequence":"first","affiliation":[{"name":"Department of Vascular & Endovascular Surgery, Katholisches Karl-Leisner-Klinikum, Marienhospital Kevelaer, Kevelaer, Nordrhein-Westfalen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland A.","family":"Stroetges","sequence":"additional","affiliation":[{"name":"Department of Vascular & Endovascular Surgery, Katholisches Karl-Leisner-Klinikum, Marienhospital Kevelaer, Kevelaer, Nordrhein-Westfalen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry E.","family":"Miller","sequence":"additional","affiliation":[{"name":"Miller Scientific Consulting, Inc, Asheville, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Schoefferle","sequence":"additional","affiliation":[{"name":"Medical Controlling, Katholisches Karl-Leisner-Klinikum, Marienhospital Kevelaer, Kevelaer, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2017,7,24]]},"reference":[{"key":"bibr1-1526602817722019","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000245819.32762.cb"},{"key":"bibr2-1526602817722019","doi-asserted-by":"publisher","DOI":"10.1016\/S0741-5214(03)00324-0"},{"key":"bibr3-1526602817722019","doi-asserted-by":"publisher","DOI":"10.2310\/6670.2009.00046"},{"key":"bibr4-1526602817722019","doi-asserted-by":"publisher","DOI":"10.1007\/BF02000279"},{"key":"bibr5-1526602817722019","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-015-0798-3"},{"key":"bibr6-1526602817722019","doi-asserted-by":"publisher","DOI":"10.1510\/icvts.2010.256784"},{"key":"bibr7-1526602817722019","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2014.12.006"},{"key":"bibr8-1526602817722019","first-page":"73","volume":"52","author":"De La Motte L","year":"2011","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"bibr9-1526602817722019","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2012.09.034"},{"key":"bibr10-1526602817722019","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2012.06.072"},{"key":"bibr11-1526602817722019","doi-asserted-by":"publisher","DOI":"10.1177\/1538574415595209"},{"key":"bibr12-1526602817722019","unstructured":"Food and Drug Administration. What is a serious adverse event? 2016.\n                      https:\/\/www.fda.gov\/safety\/medwatch\/howtoreport\/ucm053087.htm\n                      . Accessed April 28, 2017."},{"key":"bibr13-1526602817722019","doi-asserted-by":"publisher","DOI":"10.1002\/pst.433"},{"key":"bibr14-1526602817722019","doi-asserted-by":"publisher","DOI":"10.1510\/icvts.2010.242628"},{"key":"bibr15-1526602817722019","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2011.04.010"},{"key":"bibr16-1526602817722019","doi-asserted-by":"publisher","DOI":"10.1177\/145749690709600308"},{"key":"bibr17-1526602817722019","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2015.3219"}],"container-title":["Journal of Endovascular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1526602817722019","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1526602817722019","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1526602817722019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:32:16Z","timestamp":1777498336000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1526602817722019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,24]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.1177\/1526602817722019"],"URL":"https:\/\/doi.org\/10.1177\/1526602817722019","relation":{},"ISSN":["1526-6028","1545-1550"],"issn-type":[{"value":"1526-6028","type":"print"},{"value":"1545-1550","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,24]]}}}